Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

+0.57 (+0.82%)
4:04:37 PM EDT: $70.29 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.20B
Current PEN/A
Forward PE 23.59
2yr Forward PE 26.13
See more stats
Estimates Current Quarter
Revenue$44.39 Million
Adjusted EPS$0.78
See more estimates
10-Day MA$71.05
50-Day MA$69.38
200-Day MA$67.69
See more pivots

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B Stock, NASDAQ:LGND

5980 Horton Street, Suite 405, Emeryville, California 94608
United States of America
Phone: +1.858.550.7500
Number of Employees: 154


Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Emeryville, CA.